|
|
Volumn 40, Issue 5, 2008, Pages 1443-1445
|
|
Patient Outcomes and Economics of Once-Daily Tacrolimus in Renal Transplant Patients: Results of a Modeling Analysis
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
TACROLIMUS;
ACUTE GRAFT REJECTION;
ARTICLE;
CONTROLLED RELEASE FORMULATION;
COST CONTROL;
COST OF ILLNESS;
COST UTILITY ANALYSIS;
DATA BASE;
DIALYSIS;
DRUG DOSE COMPARISON;
EXTENDED RELEASE FORMULATION;
GRAFT FAILURE;
GRAFT RECIPIENT;
GRAFT SURVIVAL;
HEALTH CARE COST;
HOSPITALIZATION;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY TRANSPLANTATION;
MEDICARE;
MODEL;
MONEY;
MORTALITY;
OUTCOME ASSESSMENT;
PATIENT COMPLIANCE;
PRIORITY JOURNAL;
RETRANSPLANTATION;
SIMULATION;
STOCHASTIC MODEL;
STOCHASTIC STATE TRANSITION MODEL;
SURVIVAL TIME;
COSTS AND COST ANALYSIS;
GRAFT SURVIVAL;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
MARKOV CHAINS;
MODELS, STATISTICAL;
PATIENT COMPLIANCE;
STOCHASTIC PROCESSES;
TACROLIMUS;
TREATMENT OUTCOME;
UNITED STATES;
|
|
EID: 45749098889
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2008.03.090 Document Type: Article |
|
Times cited : (23)
|
|
References (5)
|
